<< back
Investigators in the Brain Tumor Treatment and Research Program have over $5.2 million annually in research grants from the National Institutes of Health or the Department of Defense.
Table 1: Competitively Funded Brain Tumor-related Grants by SPORE Investigators
Investigator
(Number and Title of Grant) |
Funding Source |
Total Annual Costs |
Benos, D.J., Ph.D.
R01-CA10195 Cell Biology of ASIC2 in Glioma |
NCI |
$ 322,625 |
Benveniste, E.N., Ph.D.
R21-NS54158 The Role of ING4 in Modulating the Tumorigenic Contribution of NF-kB in Gliomas
R01-NS45290 CD40 Expression and Function in Microglia
R01-NS050665 TRADD as a Regulator of Cytokine Signaling in Glia |
NINDS
NINDS
NINDS |
$ 112,000
$ 213,500
$ 208,000 |
Buchsbaum, D.J., Ph.D.
P20-CA10195 SPORE in Pancreatic Cancer, Research Program #3 “Death Receptor Monoclonal Antibodies and Chemotherapy_:Radiation Interactionr”
P50-CA097247 Molecular Therapeutics for Anaplastic Gliomas; Project 3: Death Receptor Antibody Therapy for Malignant Gliomas |
NCI
NCI |
$ 175,925
$ 58,600 |
Cassady, K.A., M.D.
P50-CA097247 Molecular Therapeutics for Anaplastic Gliomas; Project 2: Optimized Chimeric HSV for Malignant Glioma Therapy |
NCI |
$ 58,600 |
Gladson, C.L., M.D.
R01-CA 97110 The Role of TSP-1 and 2 in the Biology of Astrocytomas
R01-CA109748 The Role of Lyn in Glioma Progression and Migration
P50-CA097247 Molecular Therapeutics for Anaplastic Gliomas, Project #1 Inhibition of Anaplastic Glioma Growth by Kringle 5 (rK5)
R01-CA127620 Inhibition of Glioma Growth by a Novel Molecule |
NCI
NCI
NCI
NCI |
$ 195,544
$ 192,859
$ 58,600
$ 175,000 |
Gillespie, G.Y., Ph.D.
P01-CA071933 Engineered HSV for Treatment of Glioma – Core B
P50-CA097247 Molecular Therapeutics for Anaplastic Gliomas, |
NCI
NCI |
$ 140,680
$1,073,000 |
Lamb, Lawrence, Ph.D.
P50-CA097247 Molecular Therapeutics for Anaplastic Gliomas. Project 4: Ex Vivo Expanded gd T cells for Immunotherapy of Anaplastic Gliomas
R21-NS057341 Feasibility of gamma/delta T cell immunotherapy for glioblastoma multiforme |
NCI
NINDS |
$ 58,600
$ 200,000 |
Markert, J.M., M.D., MPH
P01-CA071933 Engineered HSV for Treatment of Glioma – Project #4
M01-RR000032 Genetically engineered HSV-1 in Malignant Glioma |
NCI
NCRR |
$1,058,156
$ 450,000 |
Nabors, L.B., M.D.
U01-CA076607 Therapeutic Studies of Anaplastic Gliomas
R01-CA 112397-01A1 Post-transcriptional regulation requires phosphorylation of HuR in gliomas |
NCI
NCI |
$ 98,034
$ 157,500 |
Sontheimer, H.W., Ph.D.
R01-NS31234 Properties and Function of Glia Ion Channels
R01-NS36692 Role of Chloride Channels in Glia and Glioma Migration
R01 NS052634 Amino-acid Transport and the Biology of Human Gliomas |
NINDS
NINDS
NINDS |
$ 218,750
$ 210,000
$ 231,250 |
|
|
